✦ LIBER ✦

Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)

✍ Scribed by E.J Davidson; R.L Faulkner; P Sehr; M Pawlita; L.J.C Smyth; D.J Burt; A.E Tomlinson; J Hickling; H.C Kitchener; P.L Stern

Book ID: 116957223
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 96 KB
Volume: 22
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2004.01.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of human papillomavirus (HPV

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

✍ A de Jong; T O’Neill; A.Y Khan; K.M.C Kwappenberg; S.E Chisholm; N.R Whittle; J. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Pre-clinical safety and efficacy of TA-C

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

✍ S.H. van der Burg; K.M.C. Kwappenberg; T. O'Neill; R.M.P. Brandt; C.J.M. Melief; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Vaccination trial with HPV16 L1E7 chimer

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)

✍ Andreas M. Kaufmann; John D. Nieland; Ingrid Jochmus; Siegfried Baur; Klaus Frie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 173 KB

## Abstract Persistent infection with human papillomaviruses (HPV) is a prerequisite for the development of cervical cancer. Vaccination with virus‐like particles (VLP) has demonstrated efficacy in prophylaxis but lacks therapeutic potential. HPV16 L1E7 chimeric virus‐like particles (CVLP) consist